This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/6216534.stm
The article has changed 10 times. There is an RSS feed of changes available.
| Version 2 | Version 3 |
|---|---|
| Expert drug trial safety advice | Expert drug trial safety advice |
| (10 minutes later) | |
| Experts investigating the drug trial which almost killed six young volunteers have made 22 recommendations on how to avoid such mistakes again. | Experts investigating the drug trial which almost killed six young volunteers have made 22 recommendations on how to avoid such mistakes again. |
| The group, set up by the health secretary, says some drugs may be best given to people who are already ill. | The group, set up by the health secretary, says some drugs may be best given to people who are already ill. |
| Also, doctors should have safety assessment training and an expert group should advise the government's drug regulatory body, the report said. | Also, doctors should have safety assessment training and an expert group should advise the government's drug regulatory body, the report said. |
| But it added trials could only be judged on a "case by case" basis. | But it added trials could only be judged on a "case by case" basis. |
| Independent advice | |
| In particular it emphasised the need to collect safety information from unpublished clinical studies. | |
| And medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), should also have access to additional advice from independent specialist experts, said the expert scientific group, led by Professor Gordon Duff. | |
| The MHRA has been accused of being too lax in its decision to approve the TGN 1412 trial that took place at Northwick Park Hospital in north London in March. | |
| The drug was designed to treat multiple sclerosis, leukaemia and arthritis. | The drug was designed to treat multiple sclerosis, leukaemia and arthritis. |
| Catastrophic consequences | |
| Its makers, German biotech company TeGenero, thought it would subtly "re-tune" the immune system. | Its makers, German biotech company TeGenero, thought it would subtly "re-tune" the immune system. |
| But instead it sent the immune system into overdrive with catastrophic consequences. | But instead it sent the immune system into overdrive with catastrophic consequences. |
| All six men who were given the drug suffered multiple organ failure. | All six men who were given the drug suffered multiple organ failure. |
| The worst affected, Ryan Wilson, had to have fingers and toes amputated. | The worst affected, Ryan Wilson, had to have fingers and toes amputated. |
| The wellbeing of volunteers must always come first Professor Gordon Duff, lead author of the report | |
| The volunteers are launching a multi-million pound damages claim against Parexel, the research company that conducted the trial at. | The volunteers are launching a multi-million pound damages claim against Parexel, the research company that conducted the trial at. |
| Lawyers representing victims of the TGN1412 clinical drug trials welcomed the report but called for a more far reaching independent enquiry to be launched. | |
| Martyn Day, the solicitor for four of the six victims, said: "The report has done a good job at looking at the lessons to be learnt but it does nothing in terms of helping my clients understand the detail of exactly what happened and what went wrong." | |
| Professor Duff said: "The alarming outcome of the TGN 1412 trial was unprecedented in the history of clinical trials, and we want to record our sympathy for all the trial volunteers. | |
| "Hearing about their experiences was valuable in making our recommendations, and we are grateful to the volunteers who were able to talk to us. | |
| "The wellbeing of volunteers must always come first. | |
| "We believe our recommendations would safeguard this in the future." |